Goldman Sachs Group Inc Palatin Technologies Inc Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.5 $24,192 - $44,801	-89,603 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.37 - $0.54 $137 - $200	-372 Reduced 0.41%	89,603 $41,000
Q4 2021 Feb 14, 2022	SELL	$0.34 - $0.86 $3,326 - $8,414	-9,784 Reduced 9.81%	89,975 $46,000
Q3 2021 Nov 10, 2021	BUY	$0.44 - $0.63 $43,893 - $62,848	99,759 New	99,759 $44,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.45M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.